Wednesday , August 21 2019
Home / bulgaria / Lina has introduced a Femoflor screen for women's health.

Lina has introduced a Femoflor screen for women's health.



[ad_1]

Microbiologist Professor Sashka Mihaylova (right) and biologist Krassimira Chernaeva have been certified to perform the analysis.

July 17, 2019, Wednesday, 10:04

By: Flagman.BG

This is a test that every woman is encouraged to do at least once in their life.

LINA Laboratory provides a new test for complex microbial analysis of a female genotyping system called "Femoflor Screen". Professor Mihailova explains the details of the study.

– Professor Mikhailova, What is "Femoflor Screen"?

– "Femoflor Screen" It is a test that simultaneously tests microorganisms commonly found in the female reproductive system, the most common cause of bacterial vaginosis and sexually transmitted diseases. Female reproductive organs live on 3 billion kinds of microorganisms such as bacteria, small fungi and viruses. The modern concept of this microorganism is "microbot". It replaces the older and more famous name "microflora". Lactic acid bacteria are the predominant bacteria in the vaginal secretion of healthy women in the breeding season. They provide acidic pH of the medium and prevent growth of other bacteria, yeast and viruses. Lactobacilli are desirable microorganisms and all women must keep track of their existence. The amount of lactic acid bacteria is determined very accurately through the "Femoflor Screen" test. If the natural balance of vaginal microbes is interrupted, the lactobacilli are reduced at the expense of the growth of other microbial groups. This condition, known as bacterial vaginitis, is often caused by Gardnerella vaginalis, Prevotella and Porphyromonas, which targets the "Femoflor Screen" test.

There are microorganisms in the female reproductive system, though small amounts do not matter, but as the microorganisms increase, other localizations lead to infection and complications. These are fungi of the genus Candida and some Mycoplasmas (Ureaplasma spp. And Mycoplasma hominis). Quantitative analysis of this microbial group is important for assessing clinical relevance.

Through the "Femoflor Screen" you will find many sexually transmitted diseases such as Mycoplasma genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, herpes simplex virus 1, herpes simplex virus 2 and Cytomegalovirus. They are responsible for complications during pregnancy, abortion or newborn disease.

– What distinguishes the "Femoflor Screens" from the research currently available in Lina Lab?

"This is the only test to determine the total number of microorganisms in the vagina and uterus Calculate the relative share of lactic acid bacteria in total microbial counts to assess the status of normal microbes.It is the cause of the most common bacterial vaginosis.The important advantages are Candida, Ureaplasma and Mycoplasma hominis. Through a new test, LINA expands research into STD infections by providing direct evidence of Herpes simplex virus 1, Herpes simplex virus 2 and Cytomegalovirus.

– How does Femoflor Screen provide information on these various microorganisms?

– This can be achieved by applying the Real-Time PCR (real-time PCR) genetic method. It reflects the latest achievements in global science and also applies to everyday laboratory work. Using modern technology, "Lina" shows the secrets of female microorganisms – the genes of all microorganisms in the vagina and uterus. Therefore, "Femoflor Screen" improves patient's diagnosis, treatment efficiency and prognosis.

– When is the "Femoflore screen" displayed?

– when the woman has symptoms or laboratory data on inflammation of the reproductive tract; At the beginning of pregnancy planning or secondary reproduction procedures; After ingestion of antibiotics, hormones, and cell proliferation for a long time. This is a test that every woman is advised to do at least once in their life.

– Are there any requirements? To conduct this study?

– Yes, there are features related to various physiological states, drug consumption, specific operations, etc. that the user testing should know. We have detailed information for both patients and healthcare professionals. Requirements for creating a "Femoflore screen" are posted on the LINE Laboratory website.

[ad_2]
Source link